全球临床试验用品市场规模、份额、成长分析，按阶段（第一阶段、第二阶段）、应用（製药和生物製药以及合约研究组织 (CRO)）- 2024-2031 年产业预测

Global Clinical Trial Supplies Market Size, Share, Growth Analysis, By Phase(Phase I, Phase II), By Application(Pharmaceutical and Biopharmaceutical, and Contract Research Organizations (CROs)) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球临床试验用品市场规模为29亿美元，预计将从2023年的30.9亿美元成长到2031年的51.1亿美元，预测期间（2024-2031年）复合年增长率为6.5%。

在全球化趋势不断增强、临床试验活动激增以及生物製剂和生物相似药测试不断升级的推动下，全球临床试验用品市场经历了显着增长。生技製药公司采用供应链管理系统来降低与研发相关的高成本，同时提高营运效率。值得注意的是，临床试验用品占研发总支出的很大一部分。此外，试验中的生物製品和温度敏感药物的日益普及导致对临床试验设施的需求增加。目前，大约 38% 的药物表现出温度敏感性，其中 35% 的后期药物被归类为生物製剂。与传统药物相比，生物製剂的不良反应发生率较低，因此对生物製剂的需求不断增加。已开发经济体和发展中经济体对生物相似药的需求增加进一步推动了市场成长。由于成本较低且病患招募流程简化，临床试验主要在发展中经济体进行。亚太、拉丁美洲、中东欧、中东等地区为生物製药公司提供了相当大的经济优势。新加坡和中国政府拨款促进生物医学研究，而拉丁美洲则因语言障碍的减少而受益于简化的患者招募。此外，发展中经济体的多样化疾病状况有利于针对罕见疾病的临床试验。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Catalent, Inc. (US)
Thermo Fisher Scientific Inc. (US)
Sharp Packaging Services (US)
PAREXEL International Corporation (US)
CordenPharma (Austria)
Almac Group (UK)
PCI Pharma Services (US)
Eurofins Scientific (Luxembourg)
ICON plc (Ireland)
Biocair International Ltd (UK)
DHL (Germany)
Marken (US)
Myoderm (US)
Movianto (Belgium)
Ancillare LP (US)
Intertek Group plc (UK)
KLIFO A/S (Denmark)
N-SIDE (Belgium)
Sharp Clinical Services (US)
PRA Health Sciences, Inc. (US)

简介目录

Product Code: SQMIG35D2077

The global clinical trial supplies market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.09 billion in 2023 to USD 5.11 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global market for clinical trial supplies has experienced remarkable growth, fueled by the increasing trend of globalization, a surge in clinical trial activities, and the escalating testing of biologics and biosimilar drugs. Biopharmaceutical companies have adopted supply chain management systems to mitigate the high costs associated with research and development while enhancing operational efficiency. Notably, clinical trial supplies constitute a significant portion of the total R&D expenditure. Furthermore, the growing prevalence of biologics and temperature-sensitive drugs under trial has led to an uptick in demand for clinical trial facilities. Presently, approximately 38% of pharmaceutical drugs exhibit temperature sensitivity, with 35% of late-phase pharmaceutical drugs being categorized as biologics. The rising demand for biologics stems from their lower incidence of adverse effects compared to traditional drugs. Market growth is further propelled by the heightened demand for biosimilars across developed and developing economies. Clinical trials predominantly take place in developing economies due to lower costs and simplified patient recruitment processes. Regions such as Asia Pacific, Latin America, Central & Eastern Europe, and the Middle East offer considerable economic advantages to biopharmaceutical companies. Governments in Singapore and China allocate funds to foster biomedical research, while Latin America benefits from simplified patient recruitment owing to reduced language barriers. Moreover, the diverse disease landscape in developing economies facilitates clinical trials focusing on rare diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the global clinical trial supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Supplies Market Segmental Analysis

The global clinical trial supplies market is segmented based on phase, application, and region. By phase, the market is segmented into phase I, phase II, phase III, and phase IV. By application, the market is segmented into pharmaceutical and biopharmaceutical, and contract research organizations (CROs). By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Clinical Trial Supplies Market

An essential catalyst for the global clinical trial supplies market is the rising need for specialized drug products, particularly biologics. These intricate therapeutic agents demand specific clinical trial supplies to uphold their safety, effectiveness, and stability throughout the trial process. Biologics, distinguished by their complex molecular structure derived from living organisms, serve as vital treatments for a spectrum of ailments. Given their unique characteristics, biologics necessitate specialized clinical trial provisions, including precise refrigeration, tailored packaging materials, and sophisticated temperature monitoring systems. The escalating demand for biologics, fueled by their proven efficacy and reduced adverse effects compared to conventional therapies, is propelling the requirement for specialized clinical trial supplies.

Restraints in the Global Clinical Trial Supplies Market

A significant obstacle facing the global clinical trial supplies market is the exorbitant cost associated with conducting clinical trials. The expenses incurred in conducting these trials have witnessed a substantial increase in recent times, posing a restraint on market expansion. Furthermore, challenges abound in patient recruitment due to the intricacies involved, alongside stringent regulatory requirements that must be adhered to throughout the trial process. These complexities not only impede the growth of the market but also pose barriers for small and mid-sized companies seeking entry, thereby constraining the overall progression of the clinical trial supplies market.

Market Trends of the Global Clinical Trial Supplies Market

An emerging trend in the global clinical trial supplies market is the integration of blockchain technology. This technology presents a decentralized and transparent system capable of tracking and managing the clinical trial supply chain effectively, from production to patient delivery. By enabling real-time tracking of supplies, blockchain technology enhances operational efficiency, minimizes errors, and strengthens data security. As such, its adoption within the clinical trial supplies market is anticipated to rise significantly in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Clinical Trial Supplies Market by Phase

Market Overview
Phase I
Phase II
Phase III
and Phase IV

Global Clinical Trial Supplies Market by Application

Market Overview
Pharmaceutical and Biopharmaceutical
and Contract Research Organizations (CROs)

Global Clinical Trial Supplies Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Catalent, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Packaging Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAREXEL International Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CordenPharma (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocair International Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DHL (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marken (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myoderm (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Movianto (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ancillare LP (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KLIFO A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
N-SIDE (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Clinical Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments